Does PEMBROLIZUMAB Cause Eosinophilia? 148 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 148 reports of Eosinophilia have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.2% of all adverse event reports for PEMBROLIZUMAB.
148
Reports of Eosinophilia with PEMBROLIZUMAB
0.2%
of all PEMBROLIZUMAB reports
2
Deaths
82
Hospitalizations
How Dangerous Is Eosinophilia From PEMBROLIZUMAB?
Of the 148 reports, 2 (1.4%) resulted in death, 82 (55.4%) required hospitalization, and 13 (8.8%) were considered life-threatening.
Is Eosinophilia Listed in the Official Label?
Yes, Eosinophilia is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Eosinophilia?
ALBUTEROL (1,054)
PREDNISONE (815)
CLOZAPINE (806)
MONTELUKAST (741)
PANTOPRAZOLE (709)
VANCOMYCIN (695)
MEPOLIZUMAB (606)
ALLOPURINOL (554)
BUDESONIDE\FORMOTEROL (553)
PIPERACILLIN\TAZOBACTAM (530)
Which PEMBROLIZUMAB Alternatives Have Lower Eosinophilia Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G